Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-01-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA label_change · 2013-01-18FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc., resulting in changes to the drug's…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Intima Media Thickness Regression in Dyslipidemic Teenagers [Phase 3]
Phase 3 clinical trial update on intima-media thickness regression in obese and dyslipidemic teenagers; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL) [NA]
A completed clinical trial evaluated the effect of saturated fat on large LDL particles and HDL cholesterol in individuals with dyslipidemia…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels [NA]
Completed clinical trial evaluating niacin (nicotinic acid) effects on endothelial function in HIV-infected individuals with low HDL cholest…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-12-07FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for fenofibrate, enabling the marketing of a generic fenofibrate product.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and gender effects of GFT505 (elafibranor) after single and multiple ascending doses; the…
-
CLINICAL_TRIALS research · 2012-11-26Clinical Trial Update: Dyslipidemia International Survey-China
An update on the Dyslipidemia International Survey conducted in China; the document lists sponsor and conditions but the trial status is unk…
-
FDA approval · 2012-11-15FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ZOCOR (simvastatin) filed by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Production of Free Fatty Acids From Blood Triglycerides
A completed Mayo Clinic clinical trial investigates production of free fatty acids from blood triglycerides; the update indicates the study …
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy [NA]
A completed clinical trial evaluated the effect of tenofovir disoproxil fumarate on lipid levels in HIV-infected adults on stable antiretrov…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Dyslipidemia Study Investigating The Increase In "Good Cholesterol" [Phase 2]
Phase 2 clinical trial evaluating an intervention to raise HDL cholesterol in dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
A clinical trial analysis comparing the risk of cardiovascular events in HIV-infected individuals treated with lopinavir/ritonavir–based HAA…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly [Phase 1]
This Phase 1 safety pharmacokinetics study evaluated the effects of mild and moderate renal impairment on the pharmacokinetics of ABT-335 wh…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia [NA]
This update reports on a completed clinical trial evaluating a low-intensity dietary counseling intervention called 'Live Well' for patients…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin [Phase 4]
Phase 4 study evaluating the efficacy and safety of rosuvastatin at 5 mg and 10 mg for dyslipidemia, sponsored by D16 Pharma & Biotec Ltd.
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation [Phase 2]
Resverlogix reports completion of a Phase 2 trial evaluating RVX-208, an apolipoprotein A-I stimulator, in patients with coronary artery dis…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Dyslipidemia in Cardiovascular Disease [Phase 4]
Phase 4 clinical trial update on dyslipidemia in cardiovascular disease reports the study status as COMPLETED.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia [Phase 3]
Phase 3 multicenter trial comparing ABT-335 plus rosuvastatin calcium to rosuvastatin monotherapy in dyslipidemia/hypercholesterolemia. The …
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides [Phase 3]
Phase 3 safety and efficacy trial comparing ABT-143 to simvastatin in individuals with dyslipidemia, hypercholesterolemia, and hypertriglyce…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease [Phase 3]
A Phase 3 trial evaluated ABT-335 in combination with rosuvastatin versus rosuvastatin alone in adults with dyslipidemia and stage 3 chronic…
-
CLINICAL_TRIALS research · 2012-07-09Clinical Trial Update: The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines [NA]
An update on a clinical trial investigating the effects of lipid-lowering and antidiabetic treatment on cytokine levels in participants with…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. [Phase 2]
Phase 2 study evaluating GW856553 effects on endothelial function and vascular compliance in individuals with dyslipidemia; the trial status…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers [Phase 1]
A Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of GSK256073A in healthy volunteers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Second Study to Determine the Effect of GSK256073A on HVTs [Phase 1]
This Phase 1 clinical trial update reports the completion of a second study evaluating the effect of GSK256073A on HVTs in healthy subjects …